Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Balmaceda

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Pain Research|April 22, 2014
Clinical trial data in support of changing guidelines in osteoarthritis treatmentCasilda M Balmaceda
BMC Musculoskeletal Disorders|January 22, 2014
Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritisCasilda M Balmaceda
Postgraduate Medicine|January 14, 2015
The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspectiveCasilda M Balmaceda
Frontiers in Psychology|October 7, 2017
The AIP Model of EMDR Therapy and Pathogenic MemoriesMichael Hase, Ute M Balmaceda, Luca Ostacoli, et al.
Neurology|February 1, 1993
Nevus of Ota and leptomeningeal melanocytic lesionsC M Balmaceda, M R Fetell, J L O'Brien, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2005
Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic studyM D Stubblefield, L T Vahdat, C M Balmaceda, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Pain Research|April 22, 2014
Clinical trial data in support of changing guidelines in osteoarthritis treatmentCasilda M Balmaceda
BMC Musculoskeletal Disorders|January 22, 2014
Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritisCasilda M Balmaceda
Postgraduate Medicine|January 14, 2015
The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspectiveCasilda M Balmaceda
Frontiers in Psychology|October 7, 2017
The AIP Model of EMDR Therapy and Pathogenic MemoriesMichael Hase, Ute M Balmaceda, Luca Ostacoli, et al.
Neurology|February 1, 1993
Nevus of Ota and leptomeningeal melanocytic lesionsC M Balmaceda, M R Fetell, J L O'Brien, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2005
Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic studyM D Stubblefield, L T Vahdat, C M Balmaceda, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.
Pageof 1